Half Year 2019 ReNeuron Group PLC Earnings Call

14/12/2018 4:30

Conference Call ReNeuron Group PLC

ReNeuron Group PLC Conference call will be held on Dec 14, 2018. During the earnings conference call's session ReNeuron Group PLC will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact ReNeuron Group PLC for this information
Schedule an online conference with QCONF conference service and get 5 free calls with online conferencing.
ReNeuron Group plc is a clinical-stage company. The Company, through its subsidiaries, is engaged in researching and developing cell-based therapies. The Company's products are allogeneic. Its CTX stem cell therapy is used for the treatment of patients left disabled by the effects of a stroke. Its human retinal progenitor cells (hRPC) stem cell candidate is used for the treatment of retinitis pigmentosa (RP). Its second CTX stem cell candidate is for the treatment of critical limb ischaemia. The Company's exosomes nanomedicine platform focuses on generating early pre-clinical data in cancer. Its ReNcell Products include ReNcellVM and ReNcellCX cell lines. It is engaged in Phase II clinical trial of CTX cells for stroke disability. It is engaged in Phase I clinical trial of CTX cells for Critical Limb Ischaemia. It is engaged in Phase I clinical trial of hRPC stem cell candidate. The Company has completed pre-clinical trials CTX-derived exosomes.
Read more Conference Call

ReNeuron Group PLC (RQE.L)

ReNeuron Group PLC Pencoed Business Park BRIDGEND     CF35 5HY P: +4420.38198400 F: +441483.534864